Title: Accelerating Therapeutics for COVID-19
Dr. Dan Hartman, Director of Integrated Development, Bill & Melinda Gates Foundation
Dr. Steven Kern, Deputy Director of Quantitative Sciences, Bill & Melinda Gates Foundation
Dr. Craig Rayner, President of Integrated Drug Development, Certara
Dr. Fran Brown, SVP of Integrated Drug Development, Certara
This webinar presented
- Lessons we can apply from past viral pandemics
- How smarter drug development accelerates therapeutics
- Activities and learnings to date at the COVID-19 Therapeutics Accelerator
- Tools, protocols, and resources for research studies in development
Certara presents COVID-19 Scientific Webinar Series
The world faces an unprecedented and growing challenge with the COVID-19 pandemic. It is imperative that we accelerate therapeutics to patients for COVID-19 and also continue to advance programs to address other critical diseases with smarter, modern drug development.
Certara is working in close partnership with biopharma, government, nonprofits and others to progress COVID-19 therapeutics and others with clinical pharmacology and model-informed drug development approaches to support critical stage-gate decisions, development strategies, clinical trial designs, and dosing optimization.
Please join our complimentary COVID-19 Scientific Webinar Series to hear from leading experts on the latest topics in drug development from dosing for special populations to managing clinical studies and regulatory filings in this uncertain environment.
Learn more and register here.